Pietro Lampertico Selected Research

lipoarabinomannan (LAM)

9/2017	Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance.
6/2012	HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Lampertico Research Topics

Disease

87	Chronic Hepatitis B 02/2024 - 04/2003
73	Fibrosis (Cirrhosis) 03/2024 - 10/2004
58	Infections 03/2024 - 12/2003
49	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 08/2003
29	Hepatitis B 11/2023 - 01/2005
27	Liver Diseases (Liver Disease) 03/2024 - 08/2003
17	Chronic Hepatitis C 01/2022 - 09/2007
15	Chronic Hepatitis (Chronic Active Hepatitis) 05/2024 - 10/2004
14	Hepatitis 11/2023 - 12/2003
10	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 04/2003
10	Hepatitis C 01/2023 - 01/2009
7	COVID-19 10/2023 - 11/2020
7	Liver Neoplasms (Liver Cancer) 07/2022 - 01/2009
6	Chronic Hepatitis D 02/2024 - 07/2023
5	Esophageal and Gastric Varices (Esophageal Varices) 01/2023 - 01/2011
5	Coinfection 01/2022 - 11/2015
5	Chronic Renal Insufficiency 01/2022 - 09/2017
5	Neoplasms (Cancer) 12/2021 - 06/2004
5	Disease Progression 01/2021 - 12/2003
4	End Stage Liver Disease 12/2023 - 02/2013
4	Persistent Infection 10/2023 - 10/2012
4	Inflammation (Inflammations) 10/2021 - 03/2007
4	Proteinuria 10/2020 - 06/2018
3	Hemorrhage 04/2024 - 01/2011
3	Varicose Veins (Varicose Vein) 04/2024 - 11/2022
3	Virus Diseases (Viral Diseases) 10/2023 - 06/2018
3	Portal Hypertension 12/2022 - 10/2019
3	Reinfection 09/2018 - 12/2003
3	Hematologic Neoplasms (Hematological Malignancy) 10/2017 - 06/2004
2	Hepatitis D 01/2024 - 01/2023
2	Breakthrough Infections 10/2023 - 01/2023
2	Autoimmune Hepatitis 10/2023 - 10/2019
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 06/2021
2	Viremia 01/2022 - 12/2015
2	Hypertension (High Blood Pressure) 11/2021 - 01/2021
2	Liver Failure 01/2021 - 07/2014
2	Fatigue 01/2021 - 11/2019
2	Pathologic Constriction (Stenosis) 01/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2021 - 08/2003
2	Alcoholic Fatty Liver 01/2021 - 06/2020
2	Alcoholism (Alcohol Abuse) 01/2020 - 01/2016
2	Hematuria 01/2020 - 06/2018

Drug/Important Bio-Agent (IBA)

56	Antiviral Agents (Antivirals)IBA 03/2024 - 12/2009
37	Hepatitis B e AntigensIBA 02/2024 - 04/2003
31	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2023 - 02/2012
28	InterferonsIBA 11/2023 - 04/2003
26	Tenofovir (Viread)FDA Link 09/2023 - 03/2012
24	entecavir FDA Link 09/2023 - 09/2006
19	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 11/2007
16	Lamivudine (Epivir)FDA Link 01/2019 - 12/2003
13	bulevirtideIBA 05/2024 - 01/2022
13	RNA (Ribonucleic Acid)IBA 01/2024 - 06/2004
12	AntigensIBA 11/2023 - 05/2005
11	glecaprevir and pibrentasvirIBA 12/2022 - 01/2019
10	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2012
8	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2011
8	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 01/2009
7	adefovirIBA 09/2017 - 12/2005
6	Sorafenib (BAY 43-9006)FDA Link 07/2022 - 08/2018
6	peginterferon alfa-2a (Pegasys)FDA Link 01/2020 - 01/2018
5	nasIBA 01/2022 - 04/2015
5	CreatinineIBA 11/2020 - 09/2011
5	Hepatitis B Core AntigensIBA 01/2020 - 02/2012
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 04/2016
4	tenofovir alafenamideIBA 01/2022 - 09/2017
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 01/2019
4	NucleosidesIBA 12/2019 - 01/2009
4	Immunoglobulins (Immunoglobulin)IBA 10/2019 - 05/2005
3	CytokinesIBA 11/2023 - 03/2007
3	COVID-19 VaccinesIBA 10/2023 - 11/2022
3	Interferon-alpha (Interferon Alfa)IBA 08/2023 - 10/2012
3	acarboxyprothrombin (PIVKA)IBA 01/2022 - 01/2020
3	EnzymesIBA 01/2019 - 05/2005
3	Rituximab (Mabthera)FDA Link 01/2019 - 07/2014
3	hepatitis B hyperimmune globulinIBA 09/2018 - 12/2003
3	Transaminases (Aminotransferases)IBA 12/2016 - 09/2007
3	adefovir dipivoxil (Hepsera)FDA Link 04/2006 - 12/2003
2	lenvatinibIBA 04/2024 - 01/2021
2	velpatasvirIBA 03/2024 - 01/2021
2	voxilaprevirIBA 03/2024 - 01/2021
2	SofosbuvirIBA 03/2024 - 01/2021
2	NAD (NADH)IBA 12/2023 - 01/2023
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2023
2	Serum AlbuminIBA 11/2022 - 11/2020
2	Vitamin K FDA Link 01/2022 - 01/2020
2	regorafenibIBA 12/2021 - 11/2019
2	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2018
2	PlasticsIBA 01/2021 - 01/2019
2	Cell-Free Nucleic AcidsIBA 01/2021 - 06/2004
2	Phospholipases (Phospholipase)IBA 12/2020 - 10/2013

Therapy/Procedure

76	Therapeutics 04/2024 - 04/2003
25	Liver Transplantation 12/2023 - 12/2003
5	Duration of Therapy 01/2023 - 08/2018
5	Drug Therapy (Chemotherapy) 01/2019 - 04/2006
3	Contraindications 01/2022 - 01/2015
2	Off-Label Use 03/2024 - 01/2023
2	Retreatment 08/2023 - 01/2021
2	Transplantation 01/2023 - 05/2005
2	Aftercare (After-Treatment) 01/2020 - 01/2016